Hair shedding after menopause makes many women ask for every blood test at once.
Labs can help, but they are the second question. The first question is the pattern: widening part, diffuse shedding, scarring hairline recession, inflamed scalp, patchy loss, traction, medication effect, nutrition change, rapid weight loss, or more than one process.
American Academy of Dermatology describes the diagnostic sequence clearly. A dermatologist asks how long the hair loss has been happening and whether it came on quickly, looks closely at the scalp, nails, and other areas with hair loss, tests hair health with gentle pulling, and uses blood tests or scalp biopsy when disease, vitamin deficiency, hormone imbalance, or infection may be causing the loss. [1]
That is the durable rule: order labs to answer a pattern-specific question, not to avoid naming the pattern.
Start with the pattern, then choose labs
Female pattern hair loss, telogen effluvium, frontal fibrosing alopecia, alopecia areata, traction alopecia, inflammatory scalp disease, and medication-related shedding can all show up after menopause. A useful lab plan is different for each.
| Pattern or clue | Labs that may become relevant | Why labs alone are not enough |
|---|---|---|
| Widening part or thinner crown density | Ferritin, thyroid-stimulating hormone, complete blood count, and androgen testing only when history supports it. [2] [8] | Female pattern hair loss is pattern-driven; a normal ferritin does not rule it out. |
| Diffuse shedding after illness, surgery, stress, weight loss, medication change, or under-eating | complete blood count, ferritin or iron studies, thyroid-stimulating hormone, vitamin D, B12, folate, nutrition review. [3] [4] | The trigger may have happened 2 to 4 months before shedding became obvious. |
| Smooth, shiny, scarred-looking hairline, eyebrow loss, redness, scale, burning, or tenderness | Dermatology review, trichoscopy, possible biopsy; labs may support but cannot diagnose scarring. [9] | Scarring alopecia is a follicle-preservation question, not a supplement question. |
| Patchy hair loss | Dermatology review; thyroid or autoimmune testing depends on history and exam. [1] | Patchy loss can require diagnosis before broad bloodwork. |
| Acne, unwanted facial hair, rapid pattern change, or polycystic ovary syndrome history | Total or free testosterone, DHEAS, prolactin, or other endocrine labs when clinically indicated. [8] | Androgen testing is not useful for every woman with shedding. |
| Scalp pustules, sores, pain, heavy scale, or infection concern | Exam, culture or biopsy when needed; labs only if systemic clues exist. [1] | Infection or inflammatory scalp disease can worsen while a patient waits on supplement trials. |
The practical question to ask is: "What result would change the plan?" If the answer is unclear, the lab may be low value.
Ferritin is useful, but not a magic answer
Iron status is one of the most common lab questions in female hair loss. The evidence supports relevance, but it does not support treating every shedding episode with iron.
A 2022 systematic review and meta-analysis included 10,029 participants. It found women with nonscarring alopecia had lower ferritin values than women without it, with a mean difference of -18.51 ng/dL, and reported that the prevalence of ferritin levels from 10 to 15 ng/dL and below was 21%. [5]
A 2025 retrospective study of 2,851 female patients with telogen effluvium found low ferritin in 1,123 of 2,413 tested patients, or 46.5%, and iron deficiency in 685 patients, or 29.5%. It also evaluated hemoglobin, vitamin B12, folic acid, thyroid tests, and ferritin in relation to telogen effluvium. [3]
One 2023 study focused on iron-deficiency-related female alopecia and proposed redefining ferritin at least 60 ng/mL, with hemoglobin at least 13.0 g/dL, as a normal range for earlier diagnosis. [6] That is useful context, but it should not be treated as a universal self-supplement rule.
| Ferritin result pattern | Better interpretation |
|---|---|
| Very low ferritin or iron deficiency with diffuse shedding | May support iron-deficiency-related shedding, especially with low intake, digestive disease, restrictive eating, blood loss, or anemia symptoms. [5] [6] |
| Low-normal ferritin with widening part | May coexist, but female pattern hair loss still needs pattern diagnosis and treatment discussion. |
| Ferritin elevated during inflammation or illness | Ferritin can rise with inflammation, so iron status may need broader interpretation. |
| Normal ferritin with heavy shedding | Does not rule out telogen effluvium, thyroid disease, medication effect, scarring alopecia, or female pattern hair loss. |
| Ferritin checked without a plan | Ask what threshold would change treatment and how iron safety will be monitored. |
American Academy of Dermatology gives the safety backstop: take iron, zinc, or biotin only when blood testing shows a deficiency, because excess supplementation can be harmful; too much iron can cause iron poisoning. [1]
Thyroid testing should answer a thyroid question
Thyroid disease can contribute to diffuse shedding, but thyroid testing should be interpreted like medical testing, not as a hair-growth optimization panel.
The American Thyroid Association says the best way to initially test thyroid function is to measure thyroid-stimulating hormone in a blood sample. It explains that a high thyroid-stimulating hormone usually indicates the thyroid gland is not making enough thyroid hormone, while a low thyroid-stimulating hormone usually indicates too much thyroid hormone, and that follow-up thyroid hormone testing helps interpret persistent abnormalities. [7]
| Clue | Why thyroid-stimulating hormone may help |
|---|---|
| Diffuse shedding plus fatigue, cold intolerance, constipation, dry skin, weight change, or menstrual history before menopause | Symptoms may support thyroid evaluation. [7] |
| Known thyroid disease, thyroid medication, amiodarone, lithium, neck radiation, or autoimmune history | Testing may clarify under- or over-treatment or disease recurrence. |
| Sudden patchy loss, scalp pustules, scarred hairline, or traction pattern | Thyroid testing may still be part of the history, but it should not delay dermatology diagnosis. |
| Borderline thyroid-stimulating hormone without symptoms | Ask whether repeat testing or free T4 is needed before assuming thyroid disease explains hair loss. [7] |
The goal is not to find a perfect thyroid-stimulating hormone for hair. The goal is to identify clinically meaningful thyroid dysfunction when the hair pattern and history make it plausible.
Telogen effluvium needs a timeline
Telogen effluvium is diffuse shedding after a physiologic or emotional stressor, medication change, illness, surgery, nutrition change, or weight loss. The trigger often happens months before the shedding looks dramatic.
The 2025 telogen effluvium study reinforces why targeted labs can matter in diffuse shedding: ferritin, iron, B12, folate, thyroid tests, and hemoglobin abnormalities were evaluated across 2,851 female patients. [3] A separate 2024 study on telogen effluvium associated with weight loss found the mean weight-loss percentage was 15.21% and the mean weight-loss rate was 3.54 kg per month among affected patients. [4]
| Timeline question | Why it matters |
|---|---|
| Did appetite, protein intake, or weight change 2 to 4 months before shedding? | Weight-loss TE can follow rapid or meaningful weight change. [4] |
| Was there a new glucagon-like peptide-1, dose escalation, nausea, constipation, or reduced intake? | The trigger may be nutrition and weight trajectory, not the medication name alone. |
| Was there surgery, fever, infection, severe stress, or major sleep disruption? | TE is often delayed after systemic stress. |
| Did a new medication start before shedding? | Medication review may be more useful than broad supplements. |
| Is the part widening at the same time? | TE can unmask or coexist with female pattern hair loss. |
This is where a lab panel can be useful: it checks whether the trigger story created deficiency, anemia, thyroid dysfunction, or another treatable contributor.
Who this fits, and who should avoid a lab-only plan
A targeted lab plan fits best when the scalp pattern has already been checked, shedding is diffuse, the timeline suggests telogen effluvium, or the history raises a specific deficiency, thyroid, anemia, medication, weight-loss, nutrition, or androgen question.
It is a worse fit when the main clue is a smooth scarred hairline, eyebrow loss, scalp pain, pustules, sores, heavy scale, sudden patchy loss, or rapid recession. Those patterns need diagnosis first because the important next step may be trichoscopy, culture, biopsy, anti-inflammatory treatment, or follicle-preserving care rather than a broader blood panel. [1] [9]
| Situation | Better next move |
|---|---|
| Diffuse shedding after weight loss, low intake, illness, surgery, stress, or medication change | Pattern review plus targeted labs for anemia, iron status, thyroid, and nutrition contributors. [3] [4] |
| Widening part without scalp inflammation | Pattern diagnosis for female pattern hair loss, with labs only when the history makes deficiency, thyroid disease, or androgen excess plausible. [2] [8] |
| Scarred-looking recession, eyebrow loss, redness, tenderness, scale, or burning | Dermatology evaluation before waiting on supplement trials or a broad panel. [9] |
| Patchy loss or painful scalp disease | Diagnostic visit first; labs only if the exam and history point to a systemic contributor. [1] |
| Low ferritin found on screening | Ask what caused the low level, whether iron is appropriate, and how treatment will be monitored. [5] [6] |
What to ask your clinician
- What pattern does my hair loss look like: female pattern loss, diffuse telogen shedding, scarring alopecia, alopecia areata, traction, inflammation, medication effect, or more than one process?
- Which labs would change the plan: complete blood count, ferritin, iron studies, thyroid-stimulating hormone, free T4, vitamin D, B12, folate, zinc, prolactin, testosterone, or DHEAS?
- What symptoms or history make thyroid testing useful in my case?
- If ferritin is low, what is the suspected cause, how will iron be dosed, and when will levels and side effects be rechecked?
- Do I have scalp signs that need dermatology review, trichoscopy, culture, or biopsy before supplement trials?
- Did weight loss, a glucagon-like peptide-1, under-eating, low protein intake, surgery, illness, or a new medication happen 2 to 4 months before shedding?
Red flags that should not wait for a routine lab panel
| Red flag | Why it changes the plan |
|---|---|
| Smooth or shiny receding hairline, eyebrow loss, burning, tenderness, redness, or scale | Frontal fibrosing alopecia and other scarring alopecias need early dermatology review. [9] |
| Pustules, sores, severe pain, crusting, or spreading scale | Infection or inflammatory scalp disease can worsen while the wrong treatment is tried. [1] |
| Sudden patchy loss | Alopecia areata or another patchy process may need specific diagnosis. |
| Hair loss with systemic symptoms such as fever, severe fatigue, unexplained weight loss, or new neurologic symptoms | The visit should look beyond hair-specific labs. |
| Rapid shedding after major weight loss, low intake, or vomiting | Nutrition, anemia, and metabolic review may matter quickly. [4] |
Bottom line
Hair-loss blood tests after menopause should support a diagnosis, not substitute for one.
Start with the pattern and timeline. Then choose targeted labs: ferritin and iron studies when deficiency or diffuse shedding fits, thyroid-stimulating hormone when thyroid disease is plausible, complete blood count when anemia is possible, androgen testing when androgen signs or a specific pattern supports it, and dermatology review when scarring or inflammation is possible.
The safer question is not "Which hair-loss blood panel should I order?" It is "What hair-loss pattern do I have, and which lab result would change the plan?"
Related reading:
- Low Ferritin After Menopause and Hair Shedding.
- Thyroid Disease After Menopause and Hair Shedding.
- glucagon-like peptide-1 Weight Loss and Hair Shedding.
- Frontal Fibrosing Alopecia After Menopause.
- Widening Part After Menopause.
- Biotin After Menopause and Lab Test Interference.
References
[1] American Academy of Dermatology. Hair loss: Diagnosis and treatment. https://www.aad.org/public/diseases/hair-loss/treatment/diagnosis-treat
[2] Dhariwala MY, Ravikumar P. An overview of the management of hair loss in women. https://pmc.ncbi.nlm.nih.gov/articles/PMC10334345/
[3] Karakoyun Ö, Ayhan E, Yıldız İ. Retrospective Review of 2851 Female Patients With Telogen Effluvium: A Single-Center Experience. J Cosmet Dermatol. 2025;24(2):e70037. doi:10.1111/jocd.70037 https://pubmed.ncbi.nlm.nih.gov/39950230/
[4] Kang DH, Kwon SH, Sim WY, Lew BL. Telogen Effluvium Associated With Weight Loss: A Single Center Retrospective Study. Ann Dermatol. 2024;36(6):384-388. doi:10.5021/ad.24.043 https://pubmed.ncbi.nlm.nih.gov/39623615/
[5] Treister-Goltzman Y, Yarza S, Peleg R. Iron Deficiency and Nonscarring Alopecia in Women: Systematic Review and Meta-Analysis. Skin Appendage Disord. 2022;8(2):83-92. doi:10.1159/000519952 https://pubmed.ncbi.nlm.nih.gov/35415182/
[6] Lin CS, Chan LY, Wang JH, Chang CH. Diagnosis and treatment of female alopecia: Focusing on the iron deficiency-related alopecia. Tzu Chi Med J. 2023;35(4):322-328. doi:10.4103/tcmj.tcmj_95_23 https://pubmed.ncbi.nlm.nih.gov/38035053/
[7] American Thyroid Association. Thyroid function tests. https://www.thyroid.org/thyroid-function-tests/
[8] Rivera R, Guerra-Tapia A. [Management of androgenetic alopecia in postmenopausal women]. Actas Dermosifiliogr. 2008;99(4):257-61. https://pubmed.ncbi.nlm.nih.gov/18394400/
[9] Alenezi S, Ezzat RZ, Miteva M. Frontal fibrosing alopecia part I - Diagnosis and clinical presentation. J Am Acad Dermatol. 2026;94(4):1059-1072. doi:10.1016/j.jaad.2024.10.126 https://pubmed.ncbi.nlm.nih.gov/39824360/